Category: Drug Discovery
Drug Discovery market research reports by Magna Intelligence
-
Global Immunomodulators Databank Market Report
Global Immunomodulators Databank Market Report The Immunomodulators market was valued at $161,393.4 Million in 2020, and is projected to reach $308,260.0 Million by 2029 growing at a CAGR of 7.50% from 2021 to 2029. Oncology segment is expected to be the highest contributor to this market, with $78, ... Read More
-
Global Multiple Myeloma Therapeutics Databank Market Report
Global Multiple Myeloma Therapeutics Databank Market Report The Multiple Myeloma Therapeutics market was valued at $19,054.2 Million in 2020, and is projected to reach $32,591.1 Million by 2029 growing at a CAGR of 6.19% from 2021 to 2029. Medication segment is expected to be the highest contributor ... Read More
-
Global Drug Screening Databank Market Report
Global Drug Screening Databank Market Report The Drug Screening market was valued at $5,721.3 Million in 2022, and is projected to reach $17,880.4 Million by 2031 growing at a CAGR of 13.57% from 2023 to 2031. Drug Screening Service segment is expected to be the highest contributor to this market, w ... Read More
-
Global Food Allergy Diagnostics & Therapeutics Databank Market Report
Global Food Allergy Diagnostics & Therapeutics Databank Market Report The Food Allergy Diagnostics & Therapeutics market was valued at $3,508.9 Million in 2022, and is projected to reach $5,920.1 Million by 2031 growing at a CAGR of 6.03% from 2023 to 2031. Diagnostic Products segment is expected to ... Read More
-
Global Attention Deficit Hyperactivity Disorder Databank Market Report
Global Attention Deficit Hyperactivity Disorder Databank Market Report The Attention Deficit Hyperactivity Disorder market was valued at $567.0 Million in 2020, and is projected to reach $1,051.5 Million by 2029 growing at a CAGR of 7.15% from 2021 to 2029. Stimulants segment is expected to be the h ... Read More
-
Global Scleroderma Therapeutics Databank Market Report
Global Scleroderma Therapeutics Databank Market Report The Scleroderma Therapeutics market was valued at $1,728.6 Million in 2022, and is projected to reach $2,688.8 Million by 2031 growing at a CAGR of 5.07% from 2023 to 2031. Immunosuppressors segment is expected to be the highest contributor to t ... Read More
-
Global Viral Conjunctivitis Pipeline Drugs Databank Market Report
Global Viral Conjunctivitis Pipeline Drugs Databank Market Report The Viral Conjunctivitis Pipeline Drugs market was valued at $3,153.2 Million in 2022, and is projected to reach $4,172.4 Million by 2031 growing at a CAGR of 3.20% from 2023 to 2031. DST-100 segment is expected to be the highest cont ... Read More
-
Global Ophthalmology Drugs Databank Market Report
Global Ophthalmology Drugs Databank Market Report The Ophthalmology Drugs market was valued at $37,185.8 Million in 2022, and is projected to reach $65,242.2 Million by 2031 growing at a CAGR of 6.49% from 2023 to 2031. Anti-VEGF Agents segment is expected to be the highest contributor to this marke ... Read More
-
Global Investigational Drug CDMO Databank Market Report.pdf
Global Investigational Drug CDMO Databank Market Report.pdf The Varicose Veins Treatment Devices market was valued at $1,315.6 Million in 2022, and is projected to reach $2,104.4 Million by 2031 growing at a CAGR of 5.40% from 2023 to 2031. Sclerotherapy segment is expected to be the highest contrib ... Read More
-
Global Acute Myeloid Leukemia Therapeutics Databank Market Report
Global Acute Myeloid Leukemia Therapeutics Databank Market Report The Acute Myeloid Leukemia Therapeutics market was valued at $8,798.5 Million in 2022, and is projected to reach $13,821.6 Million by 2031 growing at a CAGR of 5.19% from 2023 to 2031. Targeted Therapy and Immunotherapy segment is exp ... Read More
-
Global Insomnia Therapeutics Databank Market Report
Global Insomnia Therapeutics Databank Market Report The Insomnia Therapeutics market was valued at $3,158.2 Million in 2022, and is projected to reach $4,781.0 Million by 2031 growing at a CAGR of 4.76% from 2023 to 2031. Drugs segment is expected to be the highest contributor to this market, with $ ... Read More
-
Global Multiple Sclerosis Therapeutics Databank Market Report
Global Multiple Sclerosis Therapeutics Databank Market Report The Multiple Sclerosis Therapeutics market was valued at $12,659.6 Million in 2020, and is projected to reach $22,745.4 Million by 2029 growing at a CAGR of 6.77% from 2021 to 2029. Small-molecule Drugs segment is expected to be the highe ... Read More
-
Global Myelodysplastic Syndrome Drugs Databank Market Report
Global Myelodysplastic Syndrome Drugs Databank Market Report The Myelodysplastic Syndrome Drugs market was valued at $1,623.4 Million in 2022, and is projected to reach $3,116.7 Million by 2031 growing at a CAGR of 7.56% from 2023 to 2031. Immunomodulatory Drugs segment is expected to be the highest ... Read More
-
Global Investigational Drug CDMO Databank Market Report
Global Investigational Drug CDMO Databank Market Report TThe Investigational Drug CDMO market was valued at $4,665.4 Million in 2022, and is projected to reach $7,579.6 Million by 2031 growing at a CAGR of 5.58% from 2023 to 2031. Small Molecule segment is expected to be the highest contributor to t ... Read More
-
Global Liver Cancer Drugs Databank Market Report
Global Liver Cancer Drugs Databank Market Report The Liver Cancer Drugs market was valued at $2,415.6 Million in 2022, and is projected to reach $7,115.4 Million by 2031 growing at a CAGR of 12.82% from 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, ... Read More
-
Global Myeloproliferative Disorders Drugs Databank Market Report
Global Myeloproliferative Disorders Drugs Databank Market Report The Myeloproliferative Disorders Drugs market was valued at $8,315.6 Million in 2022, and is projected to reach $9,998.2 Million by 2031 growing at a CAGR of 2.11% from 2023 to 2031. Ph+ CML segment is expected to be the highest contri ... Read More
-
Global Idiopathic Pulmonary Fibrosis Treatment Databank Market Report
Global Idiopathic Pulmonary Fibrosis Treatment Databank Market Report The Idiopathic Pulmonary Fibrosis Treatment market was valued at $2,614.3 Million in 2020, and is projected to reach $6,619.3 Million by 2029 growing at a CAGR of 10.94% from 2021 to 2029. MAPK Inhibitors segment is expected to be ... Read More
-
Leading Cystic Fibrosis Therapeutics Distribution Channel Markets Databank
Leading Cystic Fibrosis Therapeutics Distribution Channel Markets Databank The Cystic Fibrosis Therapeutics market was valued at $8,500.0 Million in 2020, and is projected to reach $10,423.5 Million by 2029 growing at a CAGR of 2.33% from 2021 to 2029. Hospital segment is expected to be the highest ... Read More
-
North America Cystic Fibrosis Therapeutics Market Databank
North America Cystic Fibrosis Therapeutics Market Databank The Cystic Fibrosis Therapeutics market was valued at $8,500.0 Million in 2020, and is projected to reach $10,423.5 Million by 2029 growing at a CAGR of 2.33% from 2021 to 2029. Hospital segment is expected to be the highest contributor to t ... Read More
-
Global Cystic Fibrosis Therapeutics Market Databank
Global Cystic Fibrosis Therapeutics Market Databank The Cystic Fibrosis Therapeutics market was valued at $8,500.0 Million in 2020, and is projected to reach $10,423.5 Million by 2029 growing at a CAGR of 2.33% from 2021 to 2029. Hospital segment is expected to be the highest contributor to this mar ... Read More
-
Asia-Pacific Onychomycosis Treatment Market Databank
Asia-Pacific Onychomycosis Treatment Market Databank The Onychomycosis Treatment market was valued at $4,200.0 Million in 2020, and is projected to reach $11,101.3 Million by 2029 growing at a CAGR of 11.47% from 2021 to 2029. Drug treatment segment is expected to be the highest contributor to this ... Read More
-
Europe Cystic Fibrosis Therapeutics Market Databank
Europe Cystic Fibrosis Therapeutics Market Databank The Cystic Fibrosis Therapeutics market was valued at $8,500.0 Million in 2020, and is projected to reach $10,423.5 Million by 2029 growing at a CAGR of 2.33% from 2021 to 2029. Hospital segment is expected to be the highest contributor to this mar ... Read More
-
Leading Cystic Fibrosis Therapeutics Country Markets Databank
Leading Cystic Fibrosis Therapeutics Country Markets Databank The Cystic Fibrosis Therapeutics market was valued at $8,500.0 Million in 2020, and is projected to reach $10,423.5 Million by 2029 growing at a CAGR of 2.33% from 2021 to 2029. Asia-Pacific is expected to be the highest contributor to th ... Read More
-
Asia-Pacific Cystic Fibrosis Therapeutics Market Databank
Asia-Pacific Cystic Fibrosis Therapeutics Market Databank The Cystic Fibrosis Therapeutics market was valued at $8,500.0 Million in 2020, and is projected to reach $10,423.5 Million by 2029 growing at a CAGR of 2.33% from 2021 to 2029. Hospital segment is expected to be the highest contributor to th ... Read More
-
Leading Cystic Fibrosis Therapeutics Treatment Markets Databank
Leading Cystic Fibrosis Therapeutics Treatment Markets Databank The Cystic Fibrosis Therapeutics market was valued at $8,500.0 Million in 2020, and is projected to reach $10,423.5 Million by 2029 growing at a CAGR of 2.33% from 2021 to 2029. Route of Administration segment is expected to be the hig ... Read More
Research Assistance
